| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Cellectis S.A (NASDAQ: CLLS)
CLLS Technical Analysis
5
| As on 9th Jun 2023 CLLS STOCK Price closed @ 1.94 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 3.96 & Strong Sell for SHORT-TERM with Stoploss of 6.48 we also expect STOCK to react on Following IMPORTANT LEVELS. |
CLLSSTOCK Price
| Open | 1.97 | Change | Price | % |
| High | 1.98 | 1 Day | -0.05 | -2.51 |
| Low | 1.92 | 1 Week | 0.11 | 6.01 |
| Close | 1.94 | 1 Month | 0.00 | 0.00 |
| Volume | 22902 | 1 Year | -7.13 | -78.61 |
| 52 Week High 9.07 | 52 Week Low 1.72 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| CLLS Daily Charts |
CLLS Intraday Charts |
Whats New @ Bazaartrend |
CLLS Free Analysis |
|
|
CLLS Important Levels Intraday
| RESISTANCE | 2.06 |
| RESISTANCE | 2.02 |
| RESISTANCE | 2.00 |
| RESISTANCE | 1.97 |
| SUPPORT | 1.91 |
| SUPPORT | 1.88 |
| SUPPORT | 1.86 |
| SUPPORT | 1.82 |
CLLS Forecast May 2024
| 4th UP Forecast | 8.38 |
| 3rd UP Forecast | 6.31 |
| 2nd UP Forecast | 5.04 |
| 1st UP Forecast | 3.76 |
| 1st DOWN Forecast | 0.12 |
| 2nd DOWN Forecast | -1.16 |
| 3rd DOWN Forecast | -2.43 |
| 4th DOWN Forecast | -4.5 |
CLLS Weekly Forecast
| 4th UP Forecast | 3.44 |
| 3rd UP Forecast | 2.96 |
| 2nd UP Forecast | 2.66 |
| 1st UP Forecast | 2.37 |
| 1st DOWN Forecast | 1.51 |
| 2nd DOWN Forecast | 1.22 |
| 3rd DOWN Forecast | 0.92 |
| 4th DOWN Forecast | 0.44 |
CLLS Forecast2024
| 4th UP Forecast | 16.24 |
| 3rd UP Forecast | 11.65 |
| 2nd UP Forecast | 8.82 |
| 1st UP Forecast | 5.98 |
| 1st DOWN Forecast | -2.1 |
| 2nd DOWN Forecast | -4.94 |
| 3rd DOWN Forecast | -7.77 |
| 4th DOWN Forecast | -12.36 |
Cellectis S.A ( NASDAQ USA Symbol : CLLS )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
CLLS Business Profile
Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatment of CD19-expressing hematologic malignancies, such as acute lymphoblastic leukemia; ALLO-501 and ALLO-501A to treat relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma; ALLO-316 for the treatment of Renal Cell Carcinoma; UCART123 for the treatment of acute myeloid leukemia; and UCART22 to treat B-cell acute lymphoblastic leukemia. It is also developing UCARTCS1 and ALLO-715 for the treatment of multiple myeloma. In addition, the company produces high oleic soybean oil, other soybean products, and fiber wheat. It has strategic alliances with Allogene Therapeutics, Inc.; Les Laboratoires Servier; The University of Texas M.D. Anderson Cancer Center; and Iovance Biotherapeutics, as well as a strategic research and development collaboration with Cytovia Therapeutics, Inc. The company was founded in 1999 and is headquartered in Paris, France. Address: 8, rue de la Croix Jarry, Paris, France, 75013
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service